Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis (CT)
Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Clinical Trial on the Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis
Sponsor: Hunan Xinhui Pharmacy Limited Company
A PHASE2 clinical study on Gastritis, this trial is completed. The trial is conducted by Hunan Xinhui Pharmacy Limited Company and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
May 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Oct 2021 — May 2023 [monthly]
Recruiting PHASE2
-
May 2021 — Oct 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hunan Xinhui Pharmacy Limited Company
- University of Karachi
For direct contact, visit the study record on ClinicalTrials.gov .